ANGHAnghami Inc

Nasdaq anghami.com


$ 1.09 $ 0.01 (0.92 %)    

Tuesday, 30-Apr-2024 15:59:17 EDT
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 1.1
$ 1.09
$ 0.00 x 0
$ 0.00 x 0
$ 1.09 - $ 1.09
$ 0.63 - $ 3.49
59,372
na
32.68M
$ 0.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 whats-going-on-with-anghami-shares-today

OSN Group acquires majority stake in Anghami at $3.69 per share, creating an entertainment powerhouse with 120M users, 2.5M sub...

 anghami-and-osn-close-milestone-transaction-marking-a-strategic-expansion-in-entertainment-streaming

The transaction has received all required regulatory approvals for successful closure OSN Group's investment in Anghami ...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION